Registro:

Referencias:

• Rahib, L., Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States (2014) Cancer Res, 74, pp. 2913-2921
• Hidalgo, M., Pancreatic cancer (2010) N Engl J Med, 362, pp. 1605-1617
• Neesse, A., Stromal biology and therapy in pancreatic cancer (2011) Gut, 60, pp. 861-868
• Olive, K.P., Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer (2009) Science, 324, pp. 1457-1461
• Provenzano, P.P., Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma (2012) Cancer Cell, 21, pp. 418-429
• Jacobetz, M.A., Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer (2013) Gut, 62, pp. 112-120
• Sherman, M.H., Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy (2014) Cell, 159, pp. 80-93
• Froeling, F.E., Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression (2011) Gastroenterology, 141, pp. 1486-1497
• Rhim, A.D., Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma (2014) Cancer Cell, 25, pp. 735-747
• Özdemir, B.C., Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival (2014) Cancer Cell, 25, pp. 719-734
• Bijlsma, M.F., van Laarhoven, H.W.M., The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: A systematic review and critical appraisal (2015) Cancer Metastasis Rev, 34, pp. 97-114
• Lee, J.J., Stromal response to hedgehog signaling restrains pancreatic cancer progression (2014) Proc Natl Acad Sci USA, 111, pp. E3091-E3100
• Bachem, M.G., Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells (2005) Gastroenterology, 128, pp. 907-921
• Hwang, R.F., Cancer-associated stromal fibroblasts promote pancreatic tumor progression (2008) Cancer Res, 68, pp. 918-926
• Vonlaufen, A., Pancreatic stellate cells and pancreatic cancer cells: An unholy alliance (2008) Cancer Res, 68, pp. 7707-7710
• Xu, Z., Role of pancreatic stellate cells in pancreatic cancer metastasis (2010) Am J Pathol, 177, pp. 2585-2596
• Moir, J.A.G., Mann, J., White, S.A., The role of pancreatic stellate cells in pancreatic cancer (2015) Surg Oncol, 24, pp. 232-238
• Tang, D., Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma (2013) Int J Cancer, 132, pp. 993-1003
• Djurec, M., Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors (2018) Proc Natl Acad Sci USA, 115, pp. E1147-E1156
• Von Bernstorff, W., Systemic and local immunosuppression in pancreatic cancer patients (2001) Clin Cancer Res, 7, pp. 925s-932s
• Hiraoka, N., Onozato, K., Kosuge, T., Hirohashi, S., Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions (2006) Clin Cancer Res, 12, pp. 5423-5434
• Koido, S., Current immunotherapeutic approaches in pancreatic cancer (2011) Clin Dev Immunol, 2011, p. 267539
• Martinez-Bosch, N., Vinaixa, J., Navarro, P., Immune evasion in pancreatic cancer: From mechanisms to therapy (2018) Cancers (Basel), 10, p. E6
• Almoguera, C., Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes (1988) Cell, 53, pp. 549-554
• Hruban, R.H., Wilentz, R.E., Kern, S.E., Genetic progression in the pancreatic ducts (2000) Am J Pathol, 156, pp. 1821-1825
• Drosten, M., Guerra, C., Barbacid, M., Genetically engineered mouse models of K-Ras-driven lung and pancreatic tumors: Validation of therapeutic targets (2017) Cold Spring Harb Perspect Med
• Hingorani, S.R., Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse (2003) Cancer Cell, 4, pp. 437-450
• Guerra, C., Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence (2011) Cancer Cell, 19, pp. 728-739
• Gidekel Friedlander, S.Y., Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras (2009) Cancer Cell, 16, pp. 379-389
• Habbe, N., Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice (2008) Proc Natl Acad Sci USA, 105, pp. 18913-18918
• Carriere, C., Seeley, E.S., Goetze, T., Longnecker, D.S., Korc, M., The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia (2007) Proc Natl Acad Sci USA, 104, pp. 4437-4442
• De La, O.J.-P., Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia (2008) Proc Natl Acad Sci USA, 105, pp. 18907-18912
• Clark, C.E., Dynamics of the immune reaction to pancreatic cancer from inception to invasion (2007) Cancer Res, 67, pp. 9518-9527
• Compagno, D., Galectins: Major signaling modulators inside and outside the cell (2014) Curr Mol Med, 14, pp. 630-651
• Rabinovich, G.A., Conejo-García, J.R., Shaping the immune landscape in cancer by galectin-driven regulatory pathways (2016) J Mol Biol, 428, pp. 3266-3281
• Kaltner, H., Galectins: Their network and roles in immunity/tumor growth control (2017) Histochem Cell Biol, 147, pp. 239-256
• Camby, I., Le Mercier, M., Lefranc, F., Kiss, R., Galectin-1: A small protein with major functions (2006) Glycobiology, 16, pp. 137R-157R
• Martinez-Bosch, N., Navarro, P., Glycans and galectins: Sweet new approaches in pancreatic cancer diagnosis and treatment (2012) Pancreatic Cancer: Molecular Mechanism and Targets, pp. 305-328. , ed Srivastava SK (InTech, Rijeka, Croatia)
• Berberat, P.O., Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer (2001) J Histochem Cytochem, 49, pp. 539-549
• Iacobuzio-Donahue, C.A., Highly expressed genes in pancreatic ductal adenocarcinomas: A comprehensive characterization and comparison of the transcription profiles obtained from three major technologies (2003) Cancer Res, 63, pp. 8614-8622
• Shen, J., Person, M.D., Zhu, J., Abbruzzese, J.L., Li, D., Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry (2004) Cancer Res, 64, pp. 9018-9026
• Roda, O., Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer (2009) Gastroenterology, 136, pp. 1375-1379
• Martinez-Bosch, N., Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and hedgehog signaling activation (2014) Cancer Res, 74, pp. 3512-3524
• Xue, X., Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: An in vitro study on the microenvironment of pancreatic ductal adenocarcinoma (2011) Pancreas, 40, pp. 832-839
• Tang, D., Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer (2015) Tumour Biol, 36, pp. 5617-5626
• Qian, D., Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis (2017) Cancer Lett, 397, pp. 43-51
• Tang, D., PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-ĸB pathway (2017) Oncotarget, 8, pp. 86488-86502
• Guerra, C., Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice (2007) Cancer Cell, 11, pp. 291-302
• Méndez-Huergo, S.P., Blidner, A.G., Rabinovich, G.A., Galectins: Emerging regulatory checkpoints linking tumor immunity and angiogenesis (2017) Curr Opin Immunol, 45, pp. 8-15
• Kaneda, A., Kaminishi, M., Nakanishi, Y., Sugimura, T., Ushijima, T., Reduced expression of the insulin-induced protein 1 andp41 Arp2/3 complex genes in human gastric cancers (2002) Int J Cancer, 100, pp. 57-62
• (2017) Cancer Facts & Figures 2017, , American Cancer Society (American Cancer Society, Atlanta
• Provenzano, P.P., Hingorani, S.R., Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer (2013) Br J Cancer, 108, pp. 1-8
• Collins, M.A., Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice (2012) J Clin Invest, 122, pp. 639-653
• Ying, H., Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism (2012) Cell, 149, pp. 656-670
• Chung, W.-J., Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous (2017) Proc Natl Acad Sci USA, 114, pp. E10947-E10955
• Jones, S., Core signaling pathways in human pancreatic cancers revealed by global genomic analyses (2008) Science, 321, pp. 1801-1806
• Biankin, A.V., Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes (2012) Nature, 491, pp. 399-405
• Waddell, N., Whole genomes redefine the mutational landscape of pancreatic cancer (2015) Nature, 518, pp. 495-501
• Kugel, S., SIRT6 suppresses pancreatic cancer through control of Lin28b (2016) Cell, 165, pp. 1401-1415
• Witkiewicz, A.K., Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets (2015) Nat Commun, 6, p. 6744
• Sandgren, E.P., Quaife, C.J., Paulovich, A.G., Palmiter, R.D., Brinster, R.L., Pancreatic tumor pathogenesis reflects the causative genetic lesion (1991) Proc Natl Acad Sci USA, 88, pp. 93-97
• Fitzner, B., Galectin-1 is an inductor of pancreatic stellate cell activation (2005) Cell Signal, 17, pp. 1240-1247
• Masamune, A., Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells (2006) Am J Physiol Gastrointest Liver Physiol, 290, pp. G729-G736
• Sawai, H., Enhancement of integrins by interleukin-1alpha, and their relationship with metastatic and invasive behavior of human pancreatic ductal adenocarcinoma cells (2003) J Surg Oncol, 82, pp. 51-56
• Ottaviano, A.J., Sun, L., Ananthanarayanan, V., Munshi, H.G., Extracellular matrix–mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-β1 (2006) Cancer Res, 66, pp. 7032-7040
• Shields, M.A., Dangi-Garimella, S., Krantz, S.B., Bentrem, D.J., Munshi, H.G., Pancreatic cancer cells respond to type I collagen by inducing snail expression to promote membrane type 1 matrix metalloproteinase-dependent collagen invasion (2011) J Biol Chem, 286, pp. 10495-10504
• Padilla, L., S100A7: From mechanism to cancer therapy (2017) Oncogene, 36, pp. 6749-6761
• Bourguignon, L.Y., Zhu, H., Shao, L., Chen, Y.W., Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration (2000) J Cell Biol, 150, pp. 177-191
• Yu, X., Li, Z., TOX gene: A novel target for human cancer gene therapy (2015) Am J Cancer Res, 5, pp. 3516-3524
• Koide, T., Hayata, T., Cho, K.W.Y., Negative regulation of hedgehog signaling by the cholesterogenic enzyme 7-dehydrocholesterol reductase (2006) Development, 133, pp. 2395-2405
• Thijssen, V.L., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc Natl Acad Sci USA, 103, pp. 15975-15980
• Thijssen, V.L., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res, 70, pp. 6216-6224
• Mathieu, V., Galectin-1 in melanoma biology and related neo-angiogenesis processes (2012) J Invest Dermatol, 132, pp. 2245-2254
• Laderach, D.J., A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (2013) Cancer Res, 73, pp. 86-96
• Croci, D.O., Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma (2012) J Exp Med, 209, pp. 1985-2000
• Croci, D.O., Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors (2014) Cell, 156, pp. 744-758
• Koong, A.C., Pancreatic tumors show high levels of hypoxia (2000) Int J Radiat Oncol Biol Phys, 48, pp. 919-922
• Guillaumond, F., Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma (2013) Proc Natl Acad Sci USA, 110, pp. 3919-3924
• Le, Q.-T., Galectin-1: A link between tumor hypoxia and tumor immune privilege (2005) J Clin Oncol, 23, pp. 8932-8941
• Lewis, A.M., Varghese, S., Xu, H., Alexander, H.R., Interleukin-1 and cancer progression: The emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment (2006) J Transl Med, 4, p. 48
• Jones, D.T., Trowbridge, I.S., Harris, A.L., Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate (2006) Cancer Res, 66, pp. 2749-2756
• Holst, S., Belo, A.I., Giovannetti, E., Van Die, I., Wuhrer, M., Profiling of different pancreatic cancer cells used as models for metastatic behaviour shows large variation in their N-glycosylation (2017) Sci Rep, 7, p. 16623
• Bailey, P., Genomic analyses identify molecular subtypes of pancreatic cancer (2016) Nature, 531, pp. 47-52
• Balachandran, V.P., Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer (2017) Nature, 551, pp. 512-516
• Bayne, L.J., Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer (2012) Cancer Cell, 21, pp. 822-835
• Pylayeva-Gupta, Y., Lee, K.E., Hajdu, C.H., Miller, G., Bar-Sagi, D., Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia (2012) Cancer Cell, 21, pp. 836-847
• Ilarregui, J.M., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat Immunol, 10, pp. 981-991
• Thiemann, S., Man, J.H., Chang, M.H., Lee, B., Baum, L.G., Galectin-1 regulates tissue exit of specific dendritic cell populations (2015) J Biol Chem, 290, pp. 22662-22677
• Verschuere, T., Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity (2014) Int J Cancer, 134, pp. 873-884
• Rubinstein, N., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5, pp. 241-251
• Juszczynski, P., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc Natl Acad Sci USA, 104, pp. 13134-13139
• Soldati, R., Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments (2012) Int J Cancer, 131, pp. 1131-1141
• Banh, A., Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis (2011) Cancer Res, 71, pp. 4423-4431
• Rutkowski, M.R., Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation (2015) Cancer Cell, 27, pp. 27-40
• Dalotto-Moreno, T., Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease (2013) Cancer Res, 73, pp. 1107-1117
• Toscano, M.A., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death (2007) Nat Immunol, 8, pp. 825-834
• Tesone, A.J., Satb1 overexpression drives tumor-promoting activities in cancer-associated dendritic cells (2016) Cell Rep, 14, pp. 1774-1786
• Poirier, F., Robertson, E.J., Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin (1993) Development, 119, pp. 1229-1236
• Blois, S.M., A pivotal role for galectin-1 in fetomaternal tolerance (2007) Nat Med, 13, pp. 1450-1457
• Poncini, C.V., Trypanosoma cruzi infection imparts a regulatory program in dendritic cells and T cells via galectin-1–dependent mechanisms (2015) J Immunol, 195, pp. 3311-3324
• Martínez-Bosch, N., The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer (2016) Oncotarget, 7, pp. 48265-48279
• Pear, W.S., Nolan, G.P., Scott, M.L., Baltimore, D., Production of high-titer helper-free retroviruses by transient transfection (1993) Proc Natl Acad Sci USA, 90, pp. 8392-8396
• Dexter, D.L., Establishment and characterization of two human pancreatic cancer cell lines tumorigenic in athymic mice 1 (1982) Cancer Res, 42, pp. 2705-2714
• Tan, M.H., Characterization of a new primary human pancreatic tumor line 2 (1986) Cancer Invest, 4, pp. 15-23
• Vértesy, S., Structural significance of galectin design: Impairment of homodimer stability by linker insertion and partial reversion by ligand presence (2015) Protein Eng Des Sel, 28, pp. 199-210
• Kim, M.P., Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice (2009) Nat Protoc, 4, pp. 1670-1680

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------